Publikationen (189) Publikationen von RAFAEL VÍCTOR ARROYO GONZÁLEZ

filter_list Allergy%20and%20Immunology

2024

  1. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

    Frontiers in Immunology, Vol. 15

  2. Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

  3. Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

    Therapeutic Advances in Neurological Disorders, Vol. 17

  4. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (I)

    Revista de neurologia, Vol. 79, Núm. 1, pp. 21-29

  5. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)

    Revista de neurologia, Vol. 79, Núm. 2, pp. 51-66

2023

  1. Medical help-seeking intentions among patients with early Alzheimer’s disease

    Frontiers in Psychiatry, Vol. 14

  2. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

  3. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30

  4. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)

    Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60

2022

  1. Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192

  2. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  3. Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Biomedicines, Vol. 10, Núm. 2

  4. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study

    Frontiers in Immunology, Vol. 13

  5. High prevalence of intrathecal IgA synthesis in multiple sclerosis patients

    Scientific Reports, Vol. 12, Núm. 1

  6. Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients

    Biology, Vol. 11, Núm. 11

  7. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726

  8. Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 8, Núm. 4

  9. Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years

    Multiple Sclerosis and Related Disorders, Vol. 49

  2. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression

    Frontiers in Immunology, Vol. 12